Brief problem-solving treatment in primary care (PST-PC) was not more effective than placebo for elderly patients screened positive of psychological problems by Lam, CLK et al.
Title
Brief problem-solving treatment in primary care (PST-PC) was
not more effective than placebo for elderly patients screened
positive of psychological problems
Author(s) Lam, CLK; Fong, DYT; Chin, WY; Lee, PWH; Lam, ETP; Lo, YYC
Citation International Journal Of Geriatric Psychiatry, 2010, v. 25 n. 10, p.968-980
Issued Date 2010
URL http://hdl.handle.net/10722/125076
Rights International Journal of Geriatric Psychiatry. Copyright © JohnWiley & Sons Ltd.
 1 
 
Brief Problem-solving Treatment in Primary Care (PST-PC) Was Not More Effective 
than Placebo for Elderly Patients Screened - Positive of Psychological Problems  
 
Running Title: PST-PC for psychological problems in the elderly 
 
Cindy L.K. Lam*, MBBS, MD (HK), FRCGP, FHKAM (Family Medicine) 
Clinical Professor, Family Medicine Unit, The University of Hong Kong 
Daniel Y.T. Fong, PhD 
Assistant Professor, Department of Nursing Studies, The University of Hong Kong 
Weng-Yee Chin, MBBS, FRACGP, 
Assistant Professor, Family Medicine Unit, the University of Hong Kong  
Peter W.H. Lee, PhD  
Hon. Professor, Department of Psychiatry, The University of Hong Kong 
Elegance TP Lam, BSc, MMSc. 
Ph D Candidate, Family Medicine Unit, The University of Hong Kong 
Yvonne YC Lo, MBchB, FRACGP, FHKCFP, FHKAM (Family Medicine) 
Clinical Assistant Professor, Family Medicine Unit, The University of Hong Kong 
 
* Correspondence: Cindy L.K. Lam, Family Medicine Unit, HKU, 3/F., Ap Lei 
Chau Clinic, 161 Main Street, Ap Lei Chau, Hong Kong SAR. 
Tel: 852-25185653;  Fax: 852-28147475.  
 E mail: clklam@hku.hk 
 2 
 
Ethics Approval 
 This research project was approved by the Ethics Committee of the Faculty of 
Medicine, the University of Hong Kong (EC 1293-99). 
 
Clinical Trial Registration 
 ClinicalTrials.gov HKCTR-497. 
 
Funding  
 This project was supported by the Health Care and Promotion Fund (project ref no # 
218016) of the Food and Health Bureau, the Government of the Hong Kong SAR 
 
Acknowledgements 
 We would like to thank Dr. Stephen W.K. Chow, Dr. Kevin K.L. Pang, Dr. Johnny 
C.Y. Lam, Dr. Sam C.S. Au, Dr. Jacky H.H. Sze and Dr. Brigitte E. Schlaikier for providing 
the PST-PC.  Thanks to On-On Cheng and Alice O.L. Cheung for their assistance in data 
collection and analysis.  
 
Conflict of Interest 
None
 3 
 
Abstract 
Objectives:  To evaluate whether screening followed by brief problem-solving treatment by 
primary care doctors (PST-PC) could improve health-related quality of life (HRQOL) and 
reduce consultation rates in the elderly.   
Design: A single-blind randomised placebo controlled trial (RCT)  
Setting: Two Government funded primary care clinics in Hong Kong.   
Participants: 299 Chinese patients aged 60 years or over, with positive screening scores for 
psychological problems by the Hospital Anxiety and Depression Scale (HADS).  
Interventions: 149 subjects were randomised to receive brief problem-solving treatment 
(PST-PC) from primary care doctors (treatment) and 150 to group video-viewing (placebo). 
All subjects were followed up by telephone at 6, 12, 26 and 52 weeks. 
Main Outcome Measures: Changes in SF-36 HRQOL scores, HADS scores and monthly 
consultation rates were compared within and between groups.  
Results: Study completion rates were 69-71%.  There was significant improvement in the 
SF-36 role-emotional (RE) and mental component summary (MCS) scores at week 6 in the 
PST-PC group but not in the placebo group.  Several SF-36 scores improved significantly in 
the placebo (video) group at weeks 6 to 52.  Mixed effects analysis adjusting for baseline 
values and cofounders did not show any difference in any of the outcomes between the PST-
PC and placebo (video) groups  
Conclusions:  Screening followed by brief PST-PC was associated with a short-term 
improvement in HRQOL in Chinese elderly patients screened positive of psychological 
problems, but the HRQOL benefit was not greater than those found in the placebo group who 
participated in group-viewings of health education videos. 
Word Count: 3499 
Keywords: mental illness, problem solving treatment, primary care, screening, elderly, Chinese 
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Brief Problem-solving Treatment in Primary Care (PST-PC) Was Not More Effective 
than Placebo for Elderly Patients Screened Positive of Psychological Problems  
 
Introduction  
Psychological problems are often unrecognized and inadequately managed in the 
elderly (Hirschfeld, 2001, Lam, 1995, Liu et al., 2004, Streiner et al., 2006, Harman et al., 
2005). Screening for depression in high risk groups is recommended for earlier detection and 
better mental health outcomes (U.S. Preventive Services Task Force, 2002, Farsides and 
Dunlop, 2001, National Institute for Clinical Excellence (NICE), 2004). To date, studies have 
shown that screening enhances detection but without significant improvements to health 
(Callahan, 2001, Gilbody et al., 2001) due in part to the uncertainty of how best to manage 
these patients.  Drugs are commonly used, but are of doubtful benefit for the mild 
psychological problems typical of screened-positive cases and can have adverse effects 
especially in the elderly (Hirschfeld, 2001, Hunkeler et al., 2006, National Institute for 
Clinical Excellence (NICE), 2004, Kennedy et al., 2003, Spigset, 1999, Callahan, 2001). 
Although many elderly patients prefer psychological treatments (Gum et al., 2006), non-drug 
interventions are probably underused (National Institute for Clinical Excellence (NICE), 
2004) and provision of psychological treatments in primary care can be difficult due to lack 
of time and expertise.  NICE recommends that a stepped-care approach  with a trial of 
psychological treatment before drugs (??)  to match the needs of the patients 
Problem-solving treatment in primary care (PST-PC) is a psychological therapy 
designed to be provided by primary care workers after a short training course (Hegel et al., 
2004, Cape et al., 2000b, Kennedy et al., 2003, Arean et al., 2008).  It is a generic treatment 
which can be used in various psychological problems including depression, anxiety, and sleep 
disturbance (Malouff et al., 2007, Mynors-Wallis, 2001, Dowrick et al., 2000a) and can be 
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used at the step 2 stage of the NICE recommended stepped care.  Mynors-Wallis et al showed 
that PST-PC was as effective as antidepressants in improving symptoms and social 
functioning of patients with depression (Mynors-Wallis et al., 2000).  Although four to six 
sessions of PST-PC are usually recommended, benefit has been found with as few as three 
(Arean et al., 2008, Hegel et al., 2004, Mynors-Wallis et al., 2000). 
The aim of our study was to determine whether screening followed by brief (three 
sessions) PST-PC provided by primary care doctors could improve quality of life and reduce 
consultation rates in elderly patients with unrecognized psychological problems.  
 
Methods and subjects 
 This was a single-blind randomised placebo controlled trial (RCT) in patients from 
two Government-funded general outpatient clinics (GOPC) in Hong Kong.    Over 70% of the 
elderly in Hong Kong use GOPCs for their usual primary care, (Census & Statistics 
Department, 2001) 99% being Chinese and more than 50% being elderly with chronic 
diseases. 
 
Subjects 
 All Chinese patients aged 60 or above consulting the two GOPCs of one district in 
Hong Kong were invited to an initial screening study.   Patients were excluded if they had 
a known doctor-diagnosed psychological disease, history of taking psychotropic 
medications within the last year, suicidal plans or strong suicidal thoughts, psychotic 
symptoms, cognitive impairment or communication problem, or had already been 
recruited to the study on a previous clinic visit. Details of the sampling population and 
method are described in an earlier paper (Lam et al., 2009).   All eligible patients were 
screened with the Hospital Anxiety and Depression Scale (HADS) and those with 
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positive HADS scores were invited to participate in the RCT.  The estimated sample size 
was 300 subjects (150 each for the PST-PC and placebo groups) to detect a moderate 
effect size (0.5 SD) difference in HRQOL scores between groups by independent t test 
with a power of 80% and 95% confidence interval, allowing for  a dropout rate of 40%. 
 The numbers of patients initially screened, recruited and followed up are shown in 
Figure 1.  The response rate to the initial screening was 71.9%.   Of the 2020 patients 
who completed the initial interview, 482 screened positive with the HADS. These 
patients were found to have poorer (lower) SF-36 scores and higher consultation rates 
than screened-negative subjects and the general elderly population (Lam et al., 2009). 
299 (62.0%) screened-positive patients agreed to join the RCT.  132 (88.6%) subjects in 
the PST-PC group attended at least one session with 109 (73.2%) completing all three 
sessions. 132 (88.0%) of the placebo (video) group attended at least one session with 113 
(75.3%) completing all three sessions.  The follow-up rates at 52 weeks were  in the PST-
PC group 69% and71% in the placebo (video) group.   
Study Instruments  
The Cantonese version of the Hospital Anxiety and Depression Scale (HADS) 
(Zigmond and Snaith, 1983, Lam et al., 1995), the Chinese (HK) SF-36 Health Survey (Lam 
et al., 1998, Lam et al., 1999) and a questionnaire on service utilization, chronic morbidity 
and socio-demography were administered to each subject.  HADS cutoff scores of Anxiety 
Score (AS) ≥3 or Depression Score (DS) ≥6 were used to identify screened-positive cases of 
psychological problems. Using these cut-offs, the HADS has a sensitivity of 80% and a 
specificity of 90% in Chinese elderly primary care patients (Lam et al., 1995).   The Chinese 
(HK) SF-36 Health Survey is a generic measure of HRQOL that gives eight scale and two 
(physical and mental) component summary scores (PCS and MCS), with higher scores 
indicating better quality of life (Ware et al., 1993).   
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Randomization and Interventions after Screening 
 Subjects with positive HADS scores (AS ≥3 or DS ≥6) were invited by 
telephone to particpate in the randomised control trial (RCT).  Those who agreed were 
randomised into either the intervention (PST-PC) group or the placebo (video) group.  
The randomisation schedule was computer-generated by permuted block randomization, 
with block size randomised between 4 and 8, by a statistician who did not take part in the 
recruitment, treatment or assessment of the subjects.   
 Each subject in the PST-PC group returned to the clinic to see a Family 
Medicine trainee who was not involved in the usual care of the patient for three PST-PC 
sessions at week 1, 3 and 5 from time of screening.   The PST-PC was modified from that 
used by Mynors-Wallis et al (Mynors-Wallis et al., 2000).  Session one lasted 30 to 45 
minutes during which the doctor completed the three core tasks of PST-PC: 1. 
establishment of a positive therapeutic relationship, 2. developing a shared understanding 
of the problem, and 3. promoting change in behaviour, thoughts and emotions (Cape et al., 
2000b, Cape et al., 2000a). Sessions two and three each lasted for 20 to 30 minutes 
during which the doctor assessed the patient’s progress, answered questions and 
reinforced the patient’s coping behaviours and positive thinking. A semi-structured 
record form incorporating the seven steps of PST-PC was used to monitor treatment 
process during each session (Appendix A).  
A total of six trainees underwent the training program consisting of three 3-hour 
workshops conducted by a clinical psychologist and a package of reading materials on the 
diagnosis of mental illnesses and principles of psychological treatments.   All sessions were 
video-taped and a random sample of the first sessions of three different patients per doctor 
was assessed by the psychologist with a structured rating form on the quality of the PST-PC.   
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The assessment sessions showed that the doctors were able to establish a positive therapeutic 
relationship in 94.5%, developed a shared understanding of the problem in 88.9%, and 
promoted changes in thinking or behaviour in 83.3% of the sessions. 
 Subjects randomised to the placebo (video) group were invited to attend the 
clinic in groups of three to six at weeks 1, 3 and 5 to watch health education videos for 30 
minutes in the first session (healthy diet) and 20 minutes in each of the last two sessions 
(exercise, and physical & psychological health).    
 All subjects continued to receive their usual medical care.  
 
Follow-up Assessments and Blinding 
 Each subject was followed up by telephone 6, 12, 26 and 52 weeks after initial 
screening.   The same survey instruments (excluding socio-demography) were administered 
at each follow up by a trained interviewer who was blinded to the screening result, group 
allocation or treatment of the subject.   
 
Outcome Measures and Data Analysis 
 The primary outcomes were the Chinese (HK) SF-36 scale and summary 
scores.   Secondary outcomes included the HADS scores and number of consultations in 
the past one month (consultation rate).  The subjects’ global perception of benefit to their 
general and psychological health was also evaluated. 
For each outcome, the change from baseline was estimated by a linear mixed effects 
model that takes account of the repeated measurements per patient.  The Holm’s procedure 
was used to account for multiplicity due to multiple comparisons across different weeks from 
baseline (Holm, 1979).   Adjustment for baseline difference, socio-demographics and co-
morbidities was also made. 
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To assess the difference between PST-PC and placebo groups on each outcome, a 
linear mixed effects analysis was again used.  Both the intercept and week were taken as 
random effects and their association was left unstructured.  The indicator variable for group 
and the baseline value of the outcome variable were included as fixed effects.  The potential 
difference of the between-group difference across different weeks was examined by an 
interaction term which was removed if insignificant before the main effects were reported.  
Normality of residuals and random effects were checked.   Adjustment for the effects of 
baseline imbalance, socio-demographics, and co-morbidities, was also made to remove the 
effects from potential prognostic factors.  Consistent to the intention-to-treat (ITT) principle, 
missing values were replaced by the last observed value.  The analysis was repeated on 
subjects with missing values ignored.  To account for multiplicity due to multiple analyses of 
the eight scales and two component summary scores of the SF-36, the Holm’s procedure was 
used for considering statistical significance (Holm, 1979). 
The statistical analysis was performed by the SAS 9 and the SPSS for Windows 15.0.  
The level of significance was taken as 0.05. All estimates were accompanied by a 95% 
confidence interval, where appropriate.  
 
Results 
 All results based on the ITT principle were similar to those after ignoring the missing 
values in terms of the effect estimates, and all conclusions remained essentially the same.  
Therefore, we present only those results based on ITT.   
Table 1 shows the baseline characteristics of the study subjects, overall and by 
groups.   There was no difference between the PST-PC and placebo (video) groups 
except a higher mean HADS depression score (DS) and lower mean SF-36 mental health 
(MH) in the PST-PC group.  Those who refused further intervention (Refused RCT) had 
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similar HADS scores but lower SF-36 physical functioning (PF) score and fewer episodic 
consultations than participants of the RCT. 
 
Change in SF-36 HRQOL Scores, HADS Scores and Monthly Consultation Rates 
 The overall changes in SF-36 scores, HADS scores and consultation rates over time 
are shown in Table 2.   The changes after adjustment for DS and MH at baseline as well as 
socio-demographics and co-morbidities (not shown) were very similar and their significance 
levels were essentially the same except for those indicated in the table. There were significant 
improvements in the SF-36 mental component summary (MCS) score and the role-emotional 
(RE) score from baseline to week 6 in the PST-PC group, which were not found in the 
placebo (video) group.  There was no significant change in any SF-36 scores at 26th and 52nd 
weeks in the PST-PC group.     Several SF-36 scores increased significantly at the 6th, 12th 
and 26th weeks and the improvement in bodily pain (BP) and RE scores persisted until the 
52nd week in the placebo (video) group.   
The anxiety scores (AS) at all follow-up assessments were significantly lower 
(improved) than baseline for both the PST-PC and placebo (video) groups.  On the other hand, 
the depression score (DS) increased with time, which was statistically significant in the 
placebo (video) at all times but not significant in the PST-PC group until the 52nd week.     
 The proportion of HADS positive cases in the PST-PC and video groups dropped at 6 
weeks to 71% and 63%, respectively, and remained at similar prevalence (71% and 65%, 
respectively) until 52nd week. There was no significant change to any of the consultation rates 
in both groups. 
 Table 3 summarizes the effects of PST-PC over placebo (video) on the changes in the 
outcomes measured after baseline.  Among all the outcome variables, the SF-36 RE score 
was the only outcome in which the difference between PST-PC and placebo (video) groups 
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differed across weeks (p = 0.002 for the group by time interaction).  After accounting for 
multiplicity, PST-PC was less effective than placebo (video) in improving the SF-36 BP in all 
follow-up visits and the RE score at week 52.  However, the effects became insignificant 
after the adjustment of HADS DS and SF-36 MH score at baseline as well as the socio-
demographics and co-morbidities. 
 
Evaluation of the Interventions  
A global evaluation on the interventions was performed at week 6. The results are 
shown in table 4. Only a minority of subjects thought the PST-PC improved their general 
health (33%) or psychological health (39%) although 73% wished their family doctors could 
provide a similar service.  A significantly higher proportion of subjects in the placebo (video) 
group perceived the intervention to be beneficial to their general health (51% vs. 33%) and 
were willing to take part again (65% Vs. 51.8%).    
 
Discussion 
  This study evaluated PST-PC as a treatment for psychological problems detected by 
screening without differentiation between different psychiatric diagnoses to simulate primary 
care where psychological problems often do not conform to specific DSM diagnosis 
(Hirschfeld, 2001, The MaGPIe Research Group, 2005, Nease et al., 1999).  The HADS was 
chosen as the case finding instrument since it performs better than most other screening 
instruments and can detect different psychological problems in primary care (Nease and 
Malouin, 2003, Bjelland et al., 2002, Lam et al., 1995).  Dowrick et al found that specific 
diagnosis does not make any difference to the outcome of PST-PC (Dowrick et al., 2000b).    
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Effectiveness of PST-PC 
Most previous studies on the treatment of psychological problems have used symptom scores 
as the primary outcome measure whose clinical significance may be hard to interpret.  We 
used health-related quality of life and consultation rate as primary outcome measures because 
they are better indicators of the impact of illness on health and service.   
In our study, PST-PC resulted in short-term (6 and 12 weeks) improvements to the SF-
36 MCS and RE scores that measure mainly mental health-related quality of life, supporting the 
validity of the results. RE refers to the limitations of daily role funcitioning as a result of 
emotional problems (Ware and Sherbourne, 1992). These benefits were not found in the placebo 
(video) group indicating that a true therapeutic effect was likely.   However, the HRQOL benefit 
became insignificant by week 26 and 52.     In the study by Dowrick et. al,  improvements in  
SF-36 scores were found up to 6 months but not at 12 months (Dowrick et al., 2000a).    The 
IMPACT study found  more sustained improvements in depressive symptoms of up to 12 
months but  benefits disappeared at 24 months (Arean et al., 2008).  Of note, IMPACT subjects 
received additional maintenance group treatments, psycho-education, psychotherapy and care 
co-ordination, and were probably more motivated since they chose to receive PST-PC over 
medication or watchful waiting.  In general, most studies on PST-PC have reported short term  
benefits immediately after completion of treatment, but long term outcomes  remain unclear 
(Williams et al., 2000, Mynors-Wallis et al., 2000).    
 29% of the PST-PC group and 37% of the placebo group changed from a positive to a 
negative HADS case at week 6 with the resolution persisting until week 52.  This may have 
resulted from the interventions but it could also be a reflection of the natural history of mild 
psychological problems.  Dowrick et al found that up to 41% of the positive cases of depression 
became negative even without intervention (Dowrick et al., 2000a).   
 13 
 
The HADS  anxiety score decreased significantly in both groups at all times until week 
52 but the depression score (DS) increased suggesting the interventions had differential effects.    
Increases in the DS were significant in the placebo group at all follow-up points, but was not 
significant in the PST-PC group until week 52.  It is possible that PST-PC slowed the 
deterioration of depressive symptoms. 
There are a number of reasons why our study failed to show more significant benefits 
from PST-PC?     Firstly, PST-PC is possibly less useful for screened-positive cases than for 
clinically diagnosed depression.   A recent Dutch RCT on frequent primary care attendees 
screened positive of mental health problems did not find PST provided by nurses more 
beneficial than usual care in improving symptoms or reducing consultation rate (Schreuders et 
al., 2007). Williams et al also found PST-PC had no benefit for elderly with dysthymia or minor 
depression with little functional impairment (Williams et al., 2000).   
Another reason is that our patients were not given an option regarding treatment. Studies 
have shown that patients who are provided with choices and choose counseling themselves do 
better than those who have been randomised to it (Chilvers et al., 2001, Mynors-Wallis, 2001).  
A review into depression delivery models found that incorporation of patient preferences into 
care was associated with improved outcomes (Griffiths and Christensen, 2009).  
Finally there is the influence of culture.  PST-PC was originally developed in the UK 
and has been studied predominantly in Western patients.   Chinese patients behave differently 
from their Western counterparts when dealing with mental problems. Chinese elderly often 
somatise and attribute symptoms to physical disease. They do not acknowledge psychological 
distress easily, and prefer to avoid engaging in discussions of their psychological state.  These 
behaviours can impact PST-PC outcome, as early identification for the rationale behind 
treatment has been found to be a positive predictor to response (Hegel et al., 2002). Chinese 
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elderly patients also prefer a passive approach to medical care which also affects PST-PC 
outcomes as active participation is required. 
 
PST-PC by Primary Care Doctors 
Our study showed that young Family Medicine trainees were able to acquire the skills of 
PST-PC over a short 9-hour course.  Evaluation of the PST-PC sessions showed that our doctors 
were able to achieve the three core tasks of PST-PC in nearly 90% sessions.  The immediate 
improvement in patients’ SF-36 MCS and RE scores and the more sustained reduction in the 
HADS AS were evidence in support of their competence.  Unfortunately, the patients’ health 
benefits were only modest and transient.  One reason for this might be that the ‘dose’ of three 
sessions may have been insufficient. In reality however, the feasibility of providing more than 
three sessions would be low due to the excessive burden on professional manpower as well as 
reduced likelihood of patient adherence.  In the study by Mynors-Wallis et al, most subjects did 
not complete the intended 6 sessions (mean  4.5) and many attended three or fewer sessions 
(Mynors-Wallis et al., 2000).   A more feasible way of enhancing and sustaining the benefit 
of PST-PC would be by providing ongoing reinforcement (‘booster’) sessions incorporated 
longitudinally with subsequent regular care. The IMPACT study found that patients who were 
able to receive monthly maintenance group treatments (‘booster sessions’) following four to six 
sessions of PST achieved the greatest benefits (Arean et al., 2008).   
  
To avoid contamination, the doctor giving PST-PC was not the one providing the 
patient’s usual care.   The therapeutic effect is likely to be greater if PST-PC can be provided by 
the patient’s own family doctor.   Family doctors with more life and professional experience 
may also be more effective than our young trainees.   Furthermore, most of our subjects were 
female but five out of six PST-PC doctors in this study were male.  The scope of this study did 
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not allow the exploration on the effect of doctor characteristics on the outcome of PST-PC, 
which deserves more research.     
 
Placebo Intervention of Group Viewing of Health Education Videos  
 It was surprising to find that our placebo intervention of video viewing was just as 
effective as PST-PC.   Most studies showing effectiveness of PST-PC have compared it against 
usual care, watchful waiting or placebo drug (Malouff et al., 2007, Mynors-Wallis et al., 2000, 
Cape et al., 2000a, Williams et al., 2000).  Studies comparing PST-PC against active treatments 
including antidepressants, psycho-education or other psychological treatments have mostly 
shown no superior effect (Dowrick et al., 2000a, Malouff et al., 2007, Mynors-Wallis et al., 
2000).  The placebo and Hawthorn effects from any intervention can be quite significant in 
patients with psychological problems, and simple interventions with minimal professional input 
may prove to be as effective as intensive psychological treatments.   
 It was interesting to find that the placebo (video) group had more cases becoming HADS 
negative, and more improvements in several SF-36 HRQOL scores than the PST-PC group.  It 
is possible that viewing health education videos in small groups might have more than just a 
placebo effect through the promotion of healthy life style, social interaction and mutual support.   
This might explain why the improvements were mainly in the functioning and bodily pain 
domains instead of the mental health domain.  The effect could be similar to interpersonal 
therapy that has been found to be as effective as PST-PC (Bower, 2002, Alexopoulos et al., 
2003).   Patient acceptance and rating of video viewing was higher than that of PST-PC with 
more patients agreeable to attending similar sessions in the future. Further studies assessing the 
effectiveness of such simple activities are needed and if proven effective could easily be 
implemented into practice. 
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Limitations 
 All subjects in our study were Chinese. We believe our results can be generalizable to 
other Chinese elderly primary care patients with psychological problems detected on 
screening in Asian settings, but may not be generalizable to other elderly patients 
internationally.    
 In this study, PST-PC was delivered by Family Medicine residents who were not 
involved in the patients’ usual care. The therapeutic effect might have been greater if PST-PC 
was provided by a doctor who had a long term relationship with the patient, or who had more 
life and professional experience than our young trainees.    
 Classification by the HADS was not 100% accurate and no attempt was made to 
establish specific psychiatric diagnoses, which could have diluted the treatment effects. It is 
not known whether the treatment could be more effective for specific conditions such as 
major depression or for patients with more severe illnesses. The limited effectiveness of PST-
PC should not be extrapolated to other psychological treatments. 
 
Conclusions 
 Our study showed that Family Medicine trainees were able to successfully acquire the 
skills of PST-PC over a short 9 hour course and that it should be feasible to be incorporated 
such a course into other Family Medicine residency programs. A qualitative exploration of 
our doctors’ perceptions of their training and provision of PST-PC and its impact on their 
future practice was not within the scope of this study but will be the subject of a future paper. 
Screening followed by three sessions of brief PST-PC by primary care doctors was 
associated with a short-term improvement in mental health related quality of life (SF-36 MCS 
and RE scores) in elderly patients with previously unrecognized psychological problems, but 
benefits were not significantly better than a placebo intervention of group viewing of 
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educational videos.   Three treatment sessions might not be sufficient for sustained benefit and 
more sessions or opportunistic ‘boosters’ of PST-PC during regular consultations should be 
considered if such a treatment is being used. 
 In view of the relatively high demand on manpower and modest acceptance by patients, 
our recommendation is that PST-PC should not be used in the routine treatment for all elderly 
with screened-positive psychological problems. Instead, we propose that PST-PC should be 
considered as a treatment option in a stepped care approach for selected patients who have not 
recovered following usual care.    
Viewing of health education videos in small groups was associated with significant 
improvements in HRQOL and remission of psychological problems in the elderly. These simple 
strategies, as well as the reasons for the poor acceptability of PST-PC among such patients, are 
areas which require further evaluation.   
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Figure 1. Distribution & Follow up of Study Subjects 
Patients with AS<3 and DS<6 
(n=1371)  
Screen patients with AS>=3 or 
DS>=6 (n=482) 
Patients completed interview 
(n=2020) 
Patients approached for study 
(n=5225) 
Refused interview (n=1473) 
Patients agreed to interview 
(n=3752)
Screened before (n=991) 
Communication problems (n=456) 
Incomplete interviews (n=244) 
Left w/o noticed (n=41) 
Refused further 
intervention (n=183) 
Agree to randomized 
study (n =299) 
Randomized to counseling (n=149) 
Attended ≥1 PST-PC sessions 
Followed up at 6 weeks (n=114) 
Default FU at 6 weeks (n=35) 
Followed up at 12 weeks (n=113) 
Default FU at 12 weeks (n=36) 
Followed up at 26 weeks (n=114) 
Default FU at 26 weeks (n=35) 
Excluded from 
study (n-167) 
Followed up at 52 weeks (n=103 
Default FU at 52 weeks (n=46 
Followed up at 26 weeks (n=119) 
Default FU at 26 weeks (n=31) 
Followed up at 52 weeks (n=106 
Default FU at 52 weeks (n=44 
Followed up at 12 weeks (n=117) 
Default FU at 12 weeks (n=33) 
Followed up at 6 weeks (n=117) 
Default FU at 6 weeks (n=33) 
Randomized to video (n=150) 
Attended ≥1 video session 
Refused TI (n=76) 
Could not be 
contacted (n=35) 
Followed up at 6 weeks (n=21) 
Default FU at 6 weeks (n=61) 
Followed up at 12 weeks (n=19) 
Default FU at 12 weeks (n=53) 
Followed up at 26 weeks (n=22) 
Default FU at 26 weeks (n=50) 
Followed up at 52 weeks (n=23) 
Default FU at 52 weeks (n=49) 
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Table 1. Baseline Characteristics of Subjects 
  PST-PC Placebo (Video) 
Refused 
RCT Total 
  (n=149) (n=150) (n=72) (n=371) 
Age, in years, mean ± SD 71.6±6.5 72.0±7.0 71.2±7.8 71.7±7.0 
Male/ female, % 45.0/ 55.0  41.3 /58.7 31.9/68.1 41.0/59.0 
No formal/ any education, % 55.7/ 44.3 51.3/ 48.7 65.3/ 34.7 55.8/ 44.2 
Marital status, %     
 Married, living with spouse 65.8  61.3  68.1 64.4  
 Other status 34.2 38.7 31.9  35.6 
Occupation, %     
 Prof/ Ass. Prof./ Skilled 6.2  8.7  1.4  6.3  
 Semi-skilled/ Elementary 93.8  91.3  98.6  93.7  
Presence of chronic diseases, %     
 Yes / No 84.6/15.4  84.0/16.0  90.3/9.7 85.4 /14.6  
 ≤2 diseases 72.5  76.0 83.3 76.0  
 >2 diseases 27.5  24.0 16.7 24.0 
HADS Scores, mean ± SD     
 AS 5.0±3.7 4.7±2.8 4.5±3.0 4.8±3.2 
 DS 4.9±4.4* 3.9±3.5* 4.3±3.5 4.4±3.9 
SF-36 Scores, mean ± SD     
 PF 68.2±22.5 71.86±21.1 64.2±21.4† 68.9±21.9 
 RP 58.2±43.1 55.16±41.8 52.8±42.5 55.9±42.4 
 BP 63.7±31.8 63.56±31.3 59.0±31.6 62.7±31.5 
 GH 45.7±24.1 48.18±23.2 47.7±22.6 47.1±23.4 
 VT 53.6±22.4 57.03±21.5 56.7±18.3 55.6±21.3 
 SF 75.5±29.1 78.83±29.8 78.1±27.7 77.4±29.1 
 RE 60.2±45.6 65.55±43.4 68.5±41.4 64.0±44.0 
 MH 65.1±20.6* 69.94±21.5* 67.3±19.2 67.5±20.8 
 PCS 36.8±13.6 37.10±13. 2 33.8±12.8 36.4±13.3 
 MCS 49.2±12.3 51.66±12.9 52.7±10.3 50.9±12.2 
Monthly consultations, mean ± SD     
 WM episodic consultation 0.8±1.1 0.9±1.2 0.6±0.9† 0.8±1.1 
 All WM consultation 1.4±1.1 1.452±1.3 1.2±1.1 1.4±1.2 
 CM consultation 0.2±1.0 0.44±1.6 0.4±1.7 0.3±1.4 
 Total consultation 1.6±1.6 1.853±2.1 1.6±2.0 1.7±1.9 
 
 
PF Physical Functioning VT Vitality PCS Physical Component Summary DS HADS Depression Score 
RP Role Physical SF Social Functioning MCS Mental Component Summary WM Western Medicine 
BP Bodily Pain RE Role Emotional AS HADS Anxiety Score CM Chinese Medicine 
GH General Health MH Mental Health   
* Significant difference between counseling and video groups by appropriate chi-square or independent sample t-test, p<0.05. 
† 
 
Significant difference between participants (PST-PC and placebo (video) groups) and non-participants (refused RCT) by 
appropriate chi-square test or independent t-test, p<0.05. 
Notes 
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Table 2. Changes in SF-36 Scores, HAD Scores and Consultation Rates from Baseline 
 
Notes 
Outcome 
measure 
PST-PC Video 
Change from Week 0 (95% CI) Change from Week 0 (95% CI) 
Week 6 Week 12 Week 26 Week 52 Week 6 Week 12 Week 26 Week 52 
PF -0.23(-2.62,2.15) -1.24(-3.91,1.43) -2.28(-4.75,0.19) -2.32(-4.84,0.21) 0.34(-1.76,2.43) 0.34(-1.85,2.53) -1(-3.28,1.29) -1.9(-4.31,0.52) 
RP 5.7(-1.52,12.93) 4.19(-2.58,10.97) -0.34(-7.32,6.65) 2.35(-4.56,9.26) 8.83*(2.08,15.58) 12.17*(5.67,18.67) 4.5(-2.42,11.42) 6.17(-1.15,13.48) 
BP 2.72(-1.22,6.66) -0.68(-5.12,3.75) 0.75(-3.74,5.24) -1.11(-5.7,3.47) 5.62*(1.09,10.15) 8.41*(3.72,13.1) 5.93*(1.34,10.51) 7.37*(2.9,11.83) 
GH 4.59(0.96,8.23)† 3.67(-0.18,7.53) 1.89(-1.88,5.65) 2.46(-1.46,6.38) 4.67*(0.94,8.41)† 6.67*(2.71,10.62) 5.09*(1,9.17)† 2.35(-1.47,6.18) 
VT 3.02(-0.45,6.49) -0.4(-4.31,3.5) -3.39(-7.36,0.58) -2.18(-6.05,1.69) 2.5(-1.05,6.05) 0(-3.49,3.49) -1.07(-4.63,2.49) -0.9(-4.45,2.65) 
SF 3.1(-1.55,7.76) 2.77(-2.23,7.77) 1.85(-2.75,6.44) -1.76(-6.62,3.09) 4.75 (0.37,9.13) 4.25(-0.37,8.87) 5.67 (0.89,10.45) 2.67(-1.76,7.09) 
RE 11.41*(4.1,18.72) 9.84*(1.83,17.86)† 2.46(-5.19,10.11) 3.13(-4.88,11.14) 3.56(-3.68,10.79) 6.89(-0.51,14.29) 8.22 (1.43,15.02) 10.89*(3.97,17.81) 
MH 2.36(-0.4,5.13) 1.15(-1.76,4.07) -0.08(-3.49,3.33) 0.86(-2.31,4.03) -0.03(-2.81,2.75) -0.21(-3.47,3.04) -0.24(-3.38,2.9) -0.4(-3.31,2.51) 
PCS 0.7(-1.01,2.41) -0.11(-1.98,1.76) -0.52(-2.22,1.18) -0.54(-2.18,1.09) 2.25*(0.75,3.76) 3.1*(1.52,4.69) 1.15(-0.6,2.91) 0.8(-0.96,2.56) 
MCS 2.64*(0.84,4.44) 1.91(0.01,3.81) 0.47(-1.62,2.55) 0.74(-1.26,2.74) 0.64(-1.23,2.5) 0.29(-1.58,2.16) 1.19(-0.73,3.12) 1.07(-0.7,2.84) 
AS -0.97*(-1.52,-0.43) -1.09*(-1.7,-0.49) -1.29*(-1.89,-0.68) -1.17*(-1.84,-0.51) -1.37*(-1.83,-0.9) -1.46*(-1.94,-0.98) -1.68*(-2.16,-1.2) -1.58*(-2.09,-1.07) 
DS 0.36(-0.28,0.99) 0.6(-0.06,1.26) 0.67(-0.02,1.36) 1.13*(0.39,1.88) 0.79*(0.12,1.47) 0.87*(0.19,1.56) 0.85*(0.12,1.59) 1.4*(0.67,2.13) 
WM 
episodic 
consultation 
-0.06(-0.16,0.03) -0.09(-0.19,0.02) -0.09(-0.19,0.02) -0.11 (-0.22,0) 0.05(-0.05,0.15) 0.01(-0.1,0.12) -0.08(-0.18,0.03) -0.03(-0.15,0.09) 
Total 
consultation 0.01(-0.09,0.11) -0.08(-0.18,0.03) 0.01(-0.11,0.12) 0.03(-0.07,0.13) 0.01(-0.09,0.12) 0.06(-0.06,0.17) 0(-0.12,0.12) 0.04(-0.08,0.17) 
All WM 
consultation -2.58(-5.71,0.56) -2.1(-5.49,1.29) -1.28(-4.9,2.35) -1.3(-4.95,2.34) -0.54(-3.37,2.29) -1.16(-4.26,1.94) -1.29(-4.4,1.83) -0.47(-3.3,2.36) 
CM 
consultation 0.16(-0.04,0.36) 0.11(-0.09,0.32) 0.83(-0.49,2.15) 0.77(-0.53,2.08) 0.57(-0.74,1.88) 1.24(-0.59,3.07) 0.73(-0.6,2.06) 0.53(-0.79,1.84) 
PF Physical Functioning VT Vitality PCS Physical Component Summary DS HADS Depression Score 
RP Role Physical SF Social Functioning MCS Mental Component Summary WM Western Medicine 
BP Bodily Pain RE Role Emotional AS HADS Anxiety Score CM Chinese Medicine 
GH General Health MH Mental Health   
* Significant at 5% level of significance after adjusting for multiplicity by Holm’s procedure 
† Results after adjustment for DS and MH, socio-demographics and co-morbidity were similar except for those noted †    
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Table 3.  Estimated effects of PST-PC vs. Placebo (video) on Outcomes 
  
  
Unadjusted for potential 
confounding factors  
Adjusted for DS and MH scores at 
baseline, as well as socio-demographics 
and co-morbidity 
Outcome 
variable Difference† (95% CI) p-value  Difference† (95% CI) p-value
PF -1.94  (-4.54, 0.66) 0.145  -1.52 (-4.08, 1.03) 0.243 
RP -3.51  (-9.90, 2.88) 0.282  -1.36 (-7.90, 5.19) 0.685 
BP -6.29  (-10.50, -2.13) 0.003*  -5.21 (-9.43, 0.99) 0.016 
GH -2.73  (-6.73, 1.27) 0.181  -1.90 (-5.87, 2.07) 0.348 
VT -2.60  (-6.32, 1.11) 0.170  -2.00 (-5.72, 1.71) 0.291 
SF -4.80  (-8.92, -0.67) 0.023  -4.21 (-8.26, -0.51) 0.043 
RE at week 6 2.80  (-3.96, 9.55) 0.418  4.08 (-2.62, 10.78) 0.233 
RE at week 12 0.80  (-5.46, 7.06) 0.803  2.25 (-3.97, 8.47) 0.478 
RE at week 26 -3.86  (-9.63, 1.90) 0.189  -2.02 (-7.79, 3.75) 0.493 
RE at week 52 -12.50  (-20.00, -5.07) 0.001*  -9.95 (-17.5, -2.39) 0.010 
MH -0.70  (-3.71, 2.31) 0.649  -0.60 (-3.68, 2.47) 0.701 
PCS -2.07  (-3.86, -0.28) 0.023  -1.48 (-3.25, 0.30) 0.103 
MCS -0.60  (-2.45, 1.25) 0.524  -0.51 (-2.36, 1.35) 0.592 
AS 0.53  (-0.01, 1.08) 0.057  0.41 (-0.14, 0.96) 0.146 
DS 0.20  (-0.55, 0.96) 0.599  0.01 (-0.71, 0.74) 0.972 
WM episodic 
consultation 
-0.07  (-0.15, 0.02) 0.128  -0.09 (-0.17, -0.002) 0.045 
Total consultation -0.05  (-0.15, 0.05) 0.315  -0.07 (-0.17, 0.02) 0.129 
All WM 
consultation 
0.78  (-1.93, 3.50) 0.572  0.50 (-2.20, 3.19) 0.717 
CM consultation -0.25  (-1.25, 0.76) 0.630  -0.22 (-1.27, 0.83) 0.684 
 
 
 
PF Physical Functioning VT Vitality PCS Physical Component Summary DS HADS Depression Score 
RP Role Physical SF Social Functioning MCS Mental Component Summary WM Western Medicine 
BP Bodily Pain RE Role Emotional AS HADS Anxiety Score CM Chinese Medicine 
GH General Health MH Mental Health   
* Significant at 5% level of significance after accounting multiplicity by Holm’s procedure 
† Between intervention (PST-PC) and  placebo (Video)  
Notes
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 Table 4:  Patient Evaluation on PST-PC and Video-viewing Sessions 
 
 
 
PST-PC  
(N=112) 
 
Placebo (Video)  
(N=117) 
 
Questions 
Yes   
 n (%) 
No 
 n (%) 
Yes  
 n (%) 
No  
 n (%) 
 
Are you willing to participate again? 
 
58 
 
(51.8)† 
 
54 (48.2)† 
 
76 (65.0)† 
 
41 
 
(35.0)† 
 
Would you have participated if no 
travelling allowance were provided? 
 
62 
 
(63.3)† 
 
36 (36.7)† 
 
88 (77.9)† 
 
25 
 
(22.1)† 
 
Will you recommend others to join 
this study? 
 
34 
 
(30.4)† 
 
78 (69.6)† 
 
53 (45.3)† 
 
64 
 
(54.7)† 
 
Do you wish your family doctor to 
provide similar PSC service? 
 
81 
 
(73.0) 
 
30 (27.0) 
 
NA 
 
Did this intervention lead to any 
improvement in your general health? 
 
37 
 
 
(33.0)† 
 
 
75 (67.0)† 
 
 
60 (51.3)† 
 
 
57 
 
 
 
(48.7)† 
 
 
Did this intervention lead to any 
improvement in psychological 
health? 
 
44 
 
 
(39.3) 
 
 
68 (60.7) 
 
 
57 (48.7) 
 
 
60 
 
 
(51.3) 
 
 
Was it worth the time to join this 
study? 
 
 
108 
 
 
(96.4) 
 
 
4
 
(3.6) 
 
 
115 (98.3) 
 
 
2 
 
 
(1.7) 
 
 
 
Notes 
 
 
 
 
NA Not applicable        
† Significant difference in proportions between PST-PC and Placebo (Video) groups by Chi-square test, 
p<0.05. 
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Appendix A: Brief PST-PC for the Elderly with Psychological Problems –Assessment & 
Management Summary 
 
First Session 
 
Date:                                                                         Subject  Number :                      
 
HADS Anxiety score & symptoms: AS: (       )    
___________________________________________ 
HADS Depression score & symptoms: DS:(       ) 
 
Psychological diagnosis (please circle the main problem): 
1. Major Depression                2. Dysthymia                      3. Adjustment disorder      
4. Psychosomatisation             5.  Hypochondriasis           6. Panic disorder 
7. Generalised Anxiety            8. OCD                                9. Phobia 
10. Others, please specify :________________________  99. No psychological diagnosis 
Significant somatic symptoms: 
_________________________________________________ 
Problems in living: __________________________________________________________              
 
¾Ask the patient to identify their MAIN problem 
_________________________________ 
Severity rating of MAIN problem   
      
              1           2           3           4        5  6  7  8   9  10 
  very mild               extremely severe 
 
Solution plan: 
¾Ask patient to think of possible solutions  
¾Suggest any you can think of they haven’t mentioned 
¾List advantages and disadvantages of each possible solution  
¾Prioritize the list; allow patient to strike out impossible solutions 
¾Settle on their preferred solution: break it down into steps 
¾ Patient is to work on the first step of their preferred solution and report progress to 
you 
  24
Follow Up PSC Session 
 
PST Week: __________           Subject  Number : ___________ 
             
¾Ask the patient how his/her MAIN problem is getting on: 
 
          Severity rating of MAIN problem   
      
              1           2           3           4        5  6  7  8   9  10 
  very mild               extremely severe 
 
Solution plan: 
 
¾Ask the patient what he/she has done to solve his/her problem: 
¾Was it effective? 
¾Ask patient to think of any other possible solution: 
¾Suggest any you can think of patient has not mentioned: 
¾List advantages and disadvantages of each possible solution: 
¾Prioritize the list; allow patient to strike out impossible solutions: 
¾Settle on the preferred solution: break it down into steps: 
¾Patient is to work on the first step of their preferred solution and report progress to 
you  
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